CLINICAL_TRIALS ClinicalTrials.gov record update

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 4 and 12 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01090453
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.539982+00:00
Published At: 2014-08-15T00:00:00+00:00
Record Updated At: 2018-08-20
Results Posted At: 2014-08-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tetanus", "Hepatitis B", "Haemophilus Influenzae Type b", "Poliomyelitis", "Acellular Pertussis", "Diphtheria", "Neisseria Meningitidis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-20"
protocolSection.identificationModule.nctId: "NCT01090453"
protocolSection.identificationModule.officialTitle: "Feasibility Study of GlaxoSmithKline Biologicals\u0027 GSK2202083A Vaccine in Healthy Infants at 2, 4 and 12 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-08-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.